ABEO Company Profile and Key Details

Q: Who are the executives of ABEO?

Mr. Joseph Walter VazzanoChief Financial OfficerMr. Gregory GinVice President of Investor Relations & Corporation CommunicationsMr. Jon VossVice President & Head of QualityMr. Dmitriy Grachev M.D., Ph.D.Chief Medical OfficerScott SantiamoDirector of Corporation CommunicationsMr. Joseph Walter Vazzano CPAChief Financial OfficerDr. Vishwas Seshadri M.B.A., Ph.D.Pres, Chief Executive Officer & DirectorMr. Joseph Walter Vazzano C.P.A.Chief Financial OfficerDr. Brendan M. O'Malley J.D., Ph.D.Senior Vice President & Gen. CounselMr. Brian Kevany Ph.D.Vice President, Chief Technology Officer & Head of ResearchMs. Alison HardgroveVice President of HR

NASDAQ : ABEO

Abeona Therapeutics

$7.12

0.32+4.71%

At Close 4:00 PM

65.34

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Abeona Therapeutics Inc. (ABEO) stock surged +4.71%, trading at $7.12 on NASDAQ, up from the previous close of $6.80. The stock opened at $6.83, fluctuating between $6.83 and $7.24 in the recent session.

Stock Snapshot

6.8

Prev. Close

405.81M

Market Cap

6.83

Day Low

7.34

P/E Ratio

0.97

EPS (TTM)

-1.46

Cash Flow per Share

6.83

Open

57M

Number of Shares

7.24

Day High

88.94%

Free Float in %

0.58

Book Value

2.6M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 09, 2026	6.83	7.24	6.83	7.12	2.61M
Jul 08, 2026	6.47	6.83	6.47	6.80	1.79M
Jul 07, 2026	6.32	6.67	6.32	6.55	1.66M
Jul 06, 2026	6.43	6.59	6.22	6.31	1.42M
Jul 02, 2026	6.09	6.42	6.00	6.40	1.4M
Jul 01, 2026	6.17	6.39	6.04	6.05	2.06M
Jun 30, 2026	5.66	6.25	5.66	6.18	2.2M
Jun 29, 2026	5.60	5.69	5.52	5.66	1.31M
Jun 26, 2026	5.56	5.72	5.53	5.61	2.92M
Jun 25, 2026	5.65	5.75	5.54	5.56	1.59M
Jun 24, 2026	5.74	5.84	5.61	5.62	1.07M
Jun 23, 2026	5.68	5.87	5.67	5.72	1.02M
Jun 22, 2026	5.81	5.88	5.73	5.75	1.05M
Jun 18, 2026	5.76	5.86	5.68	5.77	1.11M
Jun 17, 2026	5.73	5.78	5.56	5.65	2.19M
Jun 16, 2026	5.67	5.80	5.60	5.65	1.56M
Jun 15, 2026	5.54	5.74	5.52	5.67	620.44K
Jun 12, 2026	5.53	5.70	5.51	5.53	957.29K
Jun 11, 2026	5.35	5.56	5.30	5.53	1.13M
Jun 10, 2026	5.41	5.53	5.28	5.36	1.01M

Contact Details

Cleveland, NY 10019

United States

https://www.abeonatherapeutics.com 646 813 4701

About Company

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-based gene therapy solutions through its proprietary AIM vector platform. The company, which was founded in 1974 and is headquartered in New York, New York, changed its name to Abeona Therapeutics Inc. in June 2015, having previously been known as PlasmaTech Biopharmaceuticals, Inc.

Stock Peers

ARGX

-5.81-0.63%

argenx SE$909.49 REGN

5.07+0.76%

Regeneron Pharmaceuticals, Inc.$667.95 MDGL

-5.39-0.95%

Madrigal Pharmaceuticals, Inc.$560.01 UTHR

-1.86-0.34%

United Therapeutics Corporation$552.48 VRTX

-1.93001-0.39%

Vertex Pharmaceuticals Incorporated$496.50 KRYS

-4.15999-1.11%

Krystal Biotech, Inc.$371.24 PRAX

0.13+0.04%

Praxis Precision Medicines, Inc.$333.12 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

7.73+2.45%

Ligand Pharmaceuticals Incorporated$322.61 ALNY

-10.70999-3.31%

Alnylam Pharmaceuticals, Inc.$312.79

Frequently Asked Questions

What is the current Abeona Therapeutics Inc. (ABEO) stock price?

Abeona Therapeutics Inc. (NASDAQ: ABEO) stock price is $7.12 in the last trading session. During the trading session, ABEO stock reached the peak price of $7.24 while $6.83 was the lowest point it dropped to. The percentage change in ABEO stock occurred in the recent session was 4.71% while the dollar amount for the price change in ABEO stock was $0.32.

ABEO's industry and sector of operation?

The NASDAQ listed ABEO is part of Biotechnology industry that operates in the broader Healthcare sector. Abeona Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ABEO?

Mr. Joseph Walter Vazzano
Chief Financial Officer
Mr. Gregory Gin
Vice President of Investor Relations & Corporation Communications
Mr. Jon Voss
Vice President & Head of Quality
Mr. Dmitriy Grachev M.D., Ph.D.
Chief Medical Officer
Scott Santiamo
Director of Corporation Communications
Mr. Joseph Walter Vazzano CPA
Chief Financial Officer
Dr. Vishwas Seshadri M.B.A., Ph.D.
Pres, Chief Executive Officer & Director
Mr. Joseph Walter Vazzano C.P.A.
Chief Financial Officer
Dr. Brendan M. O'Malley J.D., Ph.D.
Senior Vice President & Gen. Counsel
Mr. Brian Kevany Ph.D.
Vice President, Chief Technology Officer & Head of Research
Ms. Alison Hardgrove
Vice President of HR

How ABEO did perform over past 52-week?

ABEO's closing price is 78% higher than its 52-week low of $4.00 where as its distance from 52-week high of $7.54 is -5.57%.

How many employees does ABEO have?

Number of ABEO employees currently stands at 136.

Link for ABEO official website?

Official Website of ABEO is: https://www.abeonatherapeutics.com

How do I contact ABEO?

ABEO could be contacted at phone 646 813 4701 and can also be accessed through its website. ABEO operates from 1330 Avenue of the Americas, Cleveland, NY 10019, United States.

How many shares of ABEO are traded daily?

ABEO stock volume for the day was 2.6M shares. The average number of ABEO shares traded daily for last 3 months was 1.18M.

What is the market cap of ABEO currently?

The market value of ABEO currently stands at $405.81M with its latest stock price at $7.12 and 57M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	136
Beta	1.35
Sales or Revenue	$3.50M
5Y Sales Change%	-0.896%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	136
Beta	1.35
Sales or Revenue	$3.50M
5Y Sales Change%	-0.896%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ABEO Company Profile and Key Details

Abeona Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Dividend & Fair Value

Valuation Metrics

Price Forecast & Outlook

Key Takeaways